Polatuzumab vedotin Biosimilar – Research Grade
- Sizes: 0.1mg, 5mg, 10mg, 20mg, 50mg
- Category: ichorbio, Low endotoxin, biosimilar antibody, ADC
- Target: CD79b
- Clone:
- Host:
-
Datasheet Tech Support
PRODUCT DETAILS
SPECIFICATIONS |
|
---|---|
PRODUCT NAME |
Polatuzumab vedotin Biosimilar - Research Grade |
SPECIES REACTIVITY |
Human |
HOST |
|
SPECIFICITY |
Detects human CD79b. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Polatuzumab vedotin. This product is for research use only. |
PURIFICATION METHOD |
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. |
ANTIGEN DISTRIBUTION |
|
IMMUNOGEN |
|
CONCENTRATION |
|
FORMULATION |
Sterile, preservative-free, solution in PBS. BSA and Azide free. |
PURITY |
>95% by SDS-PAGE |
ENDOTOXIN |
≤ 1.0 EU/mg as determined by the LAL method |
AGGRIGATION |
|
STORAGE CONDITION |
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C. |
TARGET |
|
---|---|
TARGET |
CD79b |
CLONE |
|
SYNONYMS |
|
BACKGROUND |
|
UNIPROT |
|
PATHOGEN TEST |
|
APPLICATIONS |
Functional Assays |
APPLICATION NOTES |
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients. |
USAGE |
Products are for research use only. Not for use in diagnostic or therapeutic procedures. |